The Food and Drug Administration recently sought comments on the role of transparency for artificial intelligence and machine learning-enabled medical devices. The FDA invited comments in follow up to a recent workshop on the topic.
Continue Reading FDA Joins Other Regulators in Focus on AI and Machine Learning